Date:7/25/2011

1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: range of treatment options, clinical applications, clinical research and market acceptance of products and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2010 fiscal year, our form 10-Q filed on May 10, 2011 and our other filings with the Securities and Exchange Commission.. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Euan Thomson, Ph.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869

'/>"/>

SOURCE Accuray Incorporated Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Question Your Dentist About Potential for Cross-Contamination, Leading Infection-Control Scientist Tells Fox News
2. Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
3. Cal/OSHA Fines Prominent Pharmaceutical Firm $371,000 for Safety Violations Leading to Worker Fatality
4. DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting
5. BD Diagnostics Hires Leading Infectious Disease Diagnostics Expert to Strengthen New Product Pipeline
6. Autonomy Powers Award-Winning Website for Leading Swiss Pharmaceutical Company
7. Texas & U.S. Drug Treatment Gap to Be Highlighted at News Conference 11 a.m. June 23 By Former U.S. Drug Czar, U.S. Music Industry/Grammys Addiction Services Leader, Miss Texas 2007, San Antonio Police Chief, Nations Leading Treatment CEO, Experts
8. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
9. Hologic Acquires TCT International Co. Ltd., a Leading Distributor of Medical Products in China
10. WaferGen Closes $30 Million Financing with Three Leading Life Science Institutional Investors
11. MedClean Technologies Forms Co-Promotion Relationship With Covidien, Leading Global Healthcare Products Manufacturer